Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 563

1.

Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.

Koscielny J, Kiesewetter H, Jörg I, Harenberg J.

Clin Appl Thromb Hemost. 2007 Jul;13(3):299-307. Review.

PMID:
17636192
2.

Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran.

Harenberg J, Jörg I, Weiss C.

Eur J Clin Pharmacol. 2006 Mar;62(3):173-7. Epub 2006 Jan 14.

PMID:
16416154
3.

Ximelagatran.

Choudhury A, Goyal D, Lip GY.

Drugs Today (Barc). 2006 Jan;42(1):3-19. Review.

PMID:
16511607
4.
5.

Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.

Huisman MV, Bounameaux H.

Semin Vasc Med. 2005 Aug;5(3):276-84.

PMID:
16123915
6.

Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran.

Harenberg J, Ingrid J, Tivadar F.

Isr Med Assoc J. 2002 Nov;4(11):1003-5.

7.

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

JAMA. 2005 Feb 9;293(6):681-9.

PMID:
15701909
8.

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G; AstraZeneca Arthroplasty Study Group.

Arch Intern Med. 2001 Oct 8;161(18):2215-21.

PMID:
11575978
9.

Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.

Schulman S, Wåhlander K, Lundström T, Clason SB, Eriksson H; THRIVE III Investigators.

N Engl J Med. 2003 Oct 30;349(18):1713-21.

10.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
11.

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.

J Thromb Haemost. 2003 Oct;1(10):2119-30.

12.

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW Jr.

Ann Intern Med. 2002 Oct 15;137(8):648-55.

PMID:
12379064
13.

Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.

Eriksson H, Lundström T, Wåhlander K, Clason SB, Schulman S; THRIVE III Investigators.

Thromb Haemost. 2005 Sep;94(3):522-7.

PMID:
16268466
14.

Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.

[No authors listed]

Prescrire Int. 2005 Aug;14(78):127-32.

PMID:
16106594
15.

[Ximelagatran for treatment of venous thromboembolism].

Harenberg J, Fenyvesi T, Jörg I.

Hamostaseologie. 2002 Aug;22(3):25-9. Review. German.

PMID:
12215758
16.

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.

Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, Eskilson C, Nylander I, Frison L, Ogren M; METHRO III Study Group.

Thromb Haemost. 2003 Feb;89(2):288-96.

PMID:
12574809
17.
19.

Ximelagatran: direct thrombin inhibitor.

Ho SJ, Brighton TA.

Vasc Health Risk Manag. 2006;2(1):49-58. Review.

20.

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW Jr; EXULT A Study Group.

N Engl J Med. 2003 Oct 30;349(18):1703-12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk